Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis

Andrew Blauvelt, Tsen Fang Tsai, Richard G. Langley, Megan Miller, Yaung Kaung Shen, Yin You, Ya Wen Yang, Kim A. Papp, Luis Puig

科研成果: 期刊稿件 › 文章 › 同行评审

36 引用 （Scopus）

指纹

探究 'Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis' 的科研主题。它们共同构成独一无二的指纹。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Psychology

Keyphrases